Farnum Rhonda sold TBPH
July 14, 2025 · Form 4 insider transaction
Farnum Rhonda sold 4,000 shares of Theravance Biopharma, Inc. at $11.39 per share, a transaction worth $45.6K. The trade was recorded as open-market sale and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Disposed (sell-side)
Shares
4,000
Price
$11.39
Total value
$45.6K
InsiderFarnum Rhonda
RoleOfficer
SecurityOrdinary Shares
Transaction codeS: Open-market sale
Transaction dateJuly 14, 2025
Filing dateJuly 16, 2025
Shares owned after326,918
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
This transaction was executed in multiple trades at prices from $11.24 to $11.46 The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or any security holder of the issuer, full information regarding the number of shares and prices at which the transaction was effected.